Successful guselkumab treatment for a psoriasis patient experiencing an adrenal crisis: a case report
Dermatologists should be aware of the potential for AI when prescribing glucocorticoids (topical or systemic) to treat psoriasis. Guselkumab represents a viable therapeutic option for psoriasis patients with concurrent AI/AC.
Authors
- Yijun Shen (ORCID: https://orcid.org/0000-0002-7138-1221)
- Pingsheng Hao (ORCID: https://orcid.org/0000-0002-0376-6269)
- Nana Luo (ORCID: https://orcid.org/0000-0002-4141-6577)
- Luxin Su (ORCID: https://orcid.org/0009-0007-1640-4367)
Institutions
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1080/09546634.2025.2545297
- Citations
- 1
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.29